SecBot SecBot
8-K ·Filed May 5, 2026

ASRT

Assertio Holdings, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001104659-26-055320
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

The three-day postponement is procedural and does not alter deal terms. Monitor for the commencement of the tender offer and the filing of Schedule 14D-9 on May 8. The key risk is deal completion — any further delays or regulatory issues would be negative for ASRT shares.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
ASRT ▲ +5.82% at T+20d
NEUTRAL call +5.82% · α vs SPY +0.87% · entry $22.16 → $23.45
Next anchor: T+60d due 3mo ago
Entry = T+0 close
May 5, 2026
via day close
T+1d
+0.18%
call +0.18% · α -1.20%
$22.20
settled 6mo ago
T+5d
+0.90%
call +0.90% · α -1.08%
$22.36
settled 6mo ago
T+20d
+5.82%
call +5.82% · α +0.87%
$23.45
settled 5mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Assertio Holdings and Garda Therapeutics mutually agreed to postpone the commencement of the tender offer for all outstanding shares of Assertio from May 4 to May 8, 2026. The acquisition price remains $21.80 per share in cash, for total consideration of $153.2 million. This is a minor procedural delay and does not change the deal terms.

Key Facts

  • Tender offer commencement postponed to May 8, 2026
  • Acquisition price: $21.80 per share in cash
  • Total cash consideration: $153.2 million
  • Assertio expects to file Schedule 14D-9 on May 8, 2026
  • Tender offer for Convertible Senior Notes also postponed to May 8, 2026

Financial Impact

No change to deal value of $153.2 million or $21.80 per share

Risk Factors

  • Further delays in tender offer commencement
  • Regulatory or shareholder approval issues could derail the acquisition
  • If deal fails, Assertio's only remaining product would be Rolvedon

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-055320
Document: tm2611405d21_ex99-1.htm0001104659-26-055320
Document: 0001104659-26-055320-index-headers.html0001104659-26-055320
Document: 0001104659-26-055320-index.html0001104659-26-055320
Document: 0001104659-26-055320.txt0001104659-26-055320
10 reports for ASRT
Performance horizon
100% Hit rate @ T+20 3 of 3 directional calls Went positive at some point 3 of 4 best @ T+20▲ +23.20%Apr 9, 2026
Filters
Rows
Reports for ASRT — sortable, filterable
TypeNow
Jul 7, 2026
16w ago
25-NSE
NEUTRAL ★ 5/10
—awaiting T+20——
Jun 26, 2026
17w ago
15-12G
NEUTRAL ★ 6/10
$23.50awaiting T+20——
Jun 18, 2026
18w ago
EFFECT
NEUTRAL ★ 5/10
$23.50awaiting T+20——
Jun 16, 2026
19w ago
8-K
BULLISH ★ 7/10
$23.50awaiting T+20——
May 18, 2026
23w ago
8-K
BULLISH ★ 8/10
$23.32 $23.50▲ +0.77%▼ −0.81%—
May 8, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$22.50 $23.44▲ +4.18%▲ +4.15%—
May 5, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$22.16 $23.45▲ +5.82%▲ +0.87%—
May 4, 2026
25w ago
8-K
BULLISH ★ 8/10
$21.61 $23.43▲ +8.42%▲ +2.78%—
Apr 29, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$18.43 $23.44▲ +27.18%▲ +21.96%—
Apr 9, 2026
28w ago
8-K
BULLISH ★ 8/10
$18.02 $22.20▲ +23.20%▲ +15.63%—
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (15h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026